美股市場個股詳情
BIIB 渤健公司
- 215.200
- +6.300+3.02%
交易中 04/29 15:51 (美東)
313.32億總市值26.90市盈率TTM
218.860最高價208.544最低價173.60萬股成交量208.990今開208.900昨收3.76億成交額1.20%換手率27.00市盈率(靜)1.46億總股本319.76052周最高2.06市淨率312.15億流通值189.44052周最低--股息TTM1.45億流通股480.180歷史最高--股息率TTM4.94%振幅2.625歷史最低216.544平均價1股每手
關於渤健公司公司
生物基因公司是一家生物製藥公司，從事神經和神經退行性疾病的發現、開發和提供治療。其產品包括治療多發性硬化症的TECFIDERA、VUMERITY、AVONEX、PLEGRIDY、TYSABRI和FAMPYRA，治療SMA的SPINRAZA，治療阿爾茨海默病的ADUHELM和治療嚴重斑塊性銀屑病的FUMADERM。
公司介紹
公司代碼BIIB
公司名稱渤健公司
上市日期1991/09/17
發行價格15.00
成立日期1978
CEOMr. Christopher A. Viehbacher
所屬市場納斯達克
員工數量7570
證券類型海外普通股
年結日12-31
公司地址225 Binney Street
城市Cambridge
省份麻塞諸塞州
國家美國
郵編02142
電話1-617-679-2000
董事高管
- 姓名
- 職務
- 年薪
- Christopher A. Viehbacher
- Director, President and Chief Executive Officer
- 3048.86萬
- Dr. Ginger Gregory, PhD
- Executive Vice President and Chief Human Resources Officer
- 508.03萬
- Susan H. Alexander
- Executive Vice President and Chief Legal Officer
- 679.02萬
- Robin C. Kramer
- Senior Vice President and Chief Accounting Officer
- --
- Michael R. Mcdonnell
- Executive Vice President and Chief Financial Officer
- 720.98萬
- Nicole Murphy
- Executive Vice President, Pharmaceutical Operations and Technology
- 492.97萬
- Dr. Jane Grogan, PhD
- Executive Vice President, Head of Research
- --
- Rachid Izzar
- Executive Vice President, Global Product Strategy and Commercialization
- --
- Adam Keeney, PhD
- Executive Vice President, Head of Corporate Development
- --
- Dr. Priya Singhal, M.D.,M.P.H.
- Executive Vice President and Head of Development
- --
- Caroline D. Dorsa
- Chairman of the Board
- 42.54萬
- Monish D. Patolawala
- Director
- --
- Dr. Maria C. Freire, PhD
- Independent Director
- 35.16萬
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 41.04萬
- Susan Langer
- Independent Director
- --
- Jesus B. Mantas
- Independent Director
- 41.04萬
- Dr. Stephen A. Sherwin, M.D.
- Independent Director
- 46.04萬
- William A. Hawkins, III
- Independent Director
- 41.04萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
